Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 91
Filter
1.
Rev Inst Med Trop Sao Paulo ; 43(1): 45-50, 2001.
Article in English | MEDLINE | ID: mdl-11246283

ABSTRACT

Whipple's disease (WD) is a rare systemic disease of infectious etiology which involves the small intestine but can virtually affect any organ. We present here five cases (four males and one female) ranging in age from 20 to 59 years. All patients had intestinal involvement associated or not with clinical manifestations linked to this organ. Vegetation in the tricuspid valve was observed in one patient, suggesting endocarditis caused by Tropheryma whippelii, with disappearance of the echocardiographic alterations after treatment. In one of the male patients the initial clinical manifestation was serologically negative spondylitis, with no diarrhea occurring at any time during follow-up. Ocular involvement associated with intestinal malabsorption and significant weight loss were observed in one case. In the other two cases, diarrhea was the major clinical manifestation. All patients were diagnosed by histological examination of the jejunal mucosa and, when indicated, of extraintestinal tissues by light and electron microscopy. After antibiotic treatment, full remission of symptoms occurred in all cases. A control examination of the intestinal mucosa performed after twelve months of treatment with sulfamethoxazole-trimethoprim revealed the disappearance of T. whippelii in four patients. The remaining patient was lost to follow-up.


Subject(s)
Whipple Disease/pathology , Adult , Female , Follow-Up Studies , Humans , Male , Middle Aged , Whipple Disease/therapy
2.
Infect Immun ; 67(9): 4939-44, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10456955

ABSTRACT

Lesion size, cellular infiltration, and tissue parasitism in the footpads of BALB/c mice infected with Leishmania major were all dramatically inhibited during acute but not chronic infection with Toxoplasma gondii. Similarly, acute but not chronic toxoplasmosis at the time of infection with L. major had a strong inhibitory effect on development of acquired immune responses mediated by Th2 lymphocytes. In contrast, no major changes in Leishmania-specific Th1-mediated responses were observed in mice coinfected with T. gondii.


Subject(s)
Leishmania major/immunology , Leishmaniasis, Cutaneous/immunology , Th2 Cells/immunology , Toxoplasma/immunology , Toxoplasmosis, Animal/immunology , Animals , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL
3.
Antimicrob Agents Chemother ; 43(4): 950-3, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10103207

ABSTRACT

In germfree mice, the administration of short-chain fatty acids (SCFA) protected the intestinal mucosa from damage produced by 1-beta-D-arabinofuranosylcytosine (Ara-C). Animals receiving SCFA and Ara-C had intestinal morphologies closer to normal than the control animals, which had severe intestinal lesions. We concluded that orally administrated SCFA reduce intestinal lesions, improving the mucosa pattern of the small intestine and colon.


Subject(s)
Cytarabine/adverse effects , Fatty Acids, Volatile/therapeutic use , Intestinal Diseases/prevention & control , Protective Agents/therapeutic use , Administration, Oral , Animals , Disease Models, Animal , Fatty Acids, Volatile/adverse effects , Fatty Liver/chemically induced , Intestinal Diseases/chemically induced , Intestinal Diseases/pathology , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Mice , Protective Agents/adverse effects
4.
J Appl Microbiol ; 86(2): 331-6, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10063632

ABSTRACT

The ability of Bifidobacterium bifidum from a commercial bifidus milk to antagonize Salmonella enteritidis subsp. typhimurium in vivo, and to reduce the pathological consequences for the host, was determined using conventional and gnotobiotic mice. Conventional animals received daily, by gavage, 0.1 ml bifidus milk containing about 10(9) cfu B. bifidum and germ-free animals received a single 0.1 ml dose. The conventional and gnotobiotic groups were challenged orally with 10(2) cfu of the pathogenic bacteria 5 and/or 10 d after the beginning of treatment. Control groups were treated with milk. Bifidus milk protected both animal models against the challenge with the pathogenic bacteria, as demonstrated by survival and histopathological data. However, to obtain the protective effect in gnotobiotic animals, the treatment had to be initiated 10 d before the challenge. In experimental and control gnotobiotic mice, Salm. enteritidis subsp. typhimurium became similarly established at levels ranging from 10(8) to 10(9) viable cells g-1 of faeces and remained at these high levels until the animals died or were sacrificed. It was concluded that the protection against Salm. enteritidis subsp. typhimurium observed in conventional and gnotobiotic mice treated with bifidus milk was not due to the reduction of the intestinal populations of the pathogenic bacteria.


Subject(s)
Bifidobacterium/growth & development , Milk/microbiology , Probiotics , Salmonella Infections, Animal/prevention & control , Salmonella typhimurium/growth & development , Animals , Antibiosis , Colony Count, Microbial , Feces/microbiology , Germ-Free Life , Mice , Salmonella Infections, Animal/mortality
5.
J Endod ; 25(9): 605-8, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10687538

ABSTRACT

This work evaluated the efficacy of an improved method used to determine the frequency of bacterial infiltration and bacterial population levels and morphotypes in cavities restored with adhesive composites in conventional mice. By using the alternative methodology suggested in this work, bacteria from microleakage were recovered and identified in cavities subjected to restoration procedures that used acid etching of the dentin and dentin adhesives used with light-curing resin. The methodology presented herein seems to be more effective than the one normally used to investigate the presence of bacteria, which uses acid demineralization of dental structures for the histological processing of tissues. The results suggest that the methodology presented in this work made it possible to recover and identify Gram-negative and Gram-positive bacteria from microleakage. Frequencies of microleakage and bacterial population levels in restored cavities using two different adhesive systems were not statistically different (p < 0.05).


Subject(s)
Bacteriological Techniques , Dental Leakage/diagnosis , Dental Leakage/microbiology , Dental Pulp Cavity/microbiology , Animals , Colony Count, Microbial , Dental Restoration, Permanent , Dentin-Bonding Agents , Evaluation Studies as Topic , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Mice
6.
J Pediatr (Rio J) ; 75(1): 63-8, 1999.
Article in Portuguese | MEDLINE | ID: mdl-14685567

ABSTRACT

OBJECTIVE: To focus attention on a rare pathology of the childhood which presents premature aging of the skin and can be lethal. METHODS: The authors present a case of cutis laxa, syndrome of premature aging, in an eight year-old child, and discuss the classification, diagnosis and prognosis of the disease. RESULTS: The child presented signs of premature aging when he was four years-old. The diagnosis of cutis laxa was confirmed by skin biopsy. The patient presented heart failure, a systemic complication different from those previously described, and died at eight years of age. CONCLUSIONS: The importance of the diagnosis of cutis laxa resides in the fact that besides characteristic dermatological findings, there are frequent systemic complications that can be the focus of preventive measures, since there is no specific treatment for this disease. Genetic counseling is another important issue in this condition.

7.
J Endod ; 24(6): 405-8, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9693583

ABSTRACT

A small animal model was evaluated to study the interrelationships between microorganisms after their implantation in root canals (inferior central incisors) using germ-free (GF) and conventional (CV) mice. The selected microorganisms were: Porphyromonas endodontalis (ATCC 35406), Eubacterium lentum (ATCC 25559), Peptostreptococcus anaerobius (ATCC 27337), Fusobacterium nucleatum (ATCC 10953), Escherichia coli (ATCC 25922), and Enterococcus faecalis (ATCC 4083). Only P. anaerobius, E. coli, and E. faecalis, respectively, were able to colonize when inoculated alone into the root canal of both CV and GF mice. E. lentum, when inoculated alone colonized only in CV animals. P. endodontalis and F. nucleatum were unable to colonize in CV and GF animals after single inoculation. It is concluded that the experimental animal model presented herein is valuable for ecological studies of root canal infections and that only some strict anaerobic bacteria are able to colonize mice root canals when inoculated by themselves alone in pure culture.


Subject(s)
Bacteria, Anaerobic/growth & development , Dental Pulp Cavity/microbiology , Disease Models, Animal , Animals , Antibiosis , Bacteria, Anaerobic/metabolism , Bacteriocins/metabolism , Ecosystem , Enterococcus faecalis/growth & development , Enterococcus faecalis/metabolism , Escherichia coli/growth & development , Escherichia coli/metabolism , Eubacterium/growth & development , Eubacterium/metabolism , Fusobacterium nucleatum/growth & development , Fusobacterium nucleatum/metabolism , Germ-Free Life , Mice , Peptostreptococcus/growth & development , Peptostreptococcus/metabolism , Porphyromonas/growth & development , Porphyromonas/metabolism
8.
Appl Environ Microbiol ; 64(2): 564-8, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9464394

ABSTRACT

As is the case for Saccharomyces boulardii, Saccharomyces cerevisiae W303 protects Fisher rats against cholera toxin (CT). The addition of glucose or dinitrophenol to cells of S. boulardii grown on a nonfermentable carbon source activated trehalase in a manner similar to that observed for S.cerevisiae. The addition of CT to the same cells also resulted in trehalase activation. Experiments performed separately on the A and B subunits of CT showed that both are necessary for activation. Similarly, the addition of CT but not of its separate subunits led to a cyclic AMP (cAMP) signal in both S. boulardii and S. cerevisiae. These data suggest that trehalase stimulation by CT probably occurred through the cAMP-mediated protein phosphorylation cascade. The requirement of CT subunit B for both the cAMP signal and trehalase activation indicates the presence of a specific receptor on the yeasts able to bind to the toxin, a situation similar to that observed for mammalian cells. This hypothesis was reinforced by experiments with 125I-labeled CT showing specific binding of the toxin to yeast cells. The adhesion of CT to a receptor on the yeast surface through the B subunit and internalization of the A subunit (necessary for the cAMP signal and trehalase activation) could be one more mechanism explaining protection against the toxin observed for rats treated with yeasts.


Subject(s)
Cholera Toxin/pharmacology , Saccharomyces cerevisiae/metabolism , Saccharomyces/metabolism , Animals , Cholera Toxin/metabolism , Cyclic AMP/biosynthesis , Male , Rats , Rats, Inbred F344 , Saccharomyces/drug effects , Saccharomyces cerevisiae/drug effects , Trehalase/metabolism
9.
Rev Inst Med Trop Sao Paulo ; 40(6): 355-62, 1998.
Article in English | MEDLINE | ID: mdl-10436655

ABSTRACT

Germfree (GF) and conventional (CV) mice were fed on diets containing 4.4, 13.2 or 26.4% of protein (weight/weight). CV mice fed on low protein diet did not gain weight during four weeks, whereas the protein deficient diet did not affect the growth of GF mice. After four weeks on these diets, the mice were inoculated with 5 x 10(3) trypomastigotes of Trypanosoma cruzi. The protein deficiency affected less the GF than the CV mice, according to the following parameters: weight gain, hemoglobin, plasma protein and albumin levels and water and protein contents of the carcass. Infection with T. cruzi produced a significant decrease in hemoglobin levels, red blood cell count, and water and protein contents in the carcass. This decrease was more pronounced in the GF mice. Histopathologically, there was no difference between the treatments in animals with the same microbiological status (GF or CV). However, the disease was more severe in the GF than in the CV mice.


Subject(s)
Chagas Disease/parasitology , Dietary Proteins/administration & dosage , Germ-Free Life , Animals , Blood Proteins/analysis , Chagas Disease/blood , Erythrocyte Count , Hemoglobins/analysis , Leukocyte Count , Male , Mice , Serum Albumin/analysis , Weight Gain
10.
J Med Microbiol ; 47(2): 111-6, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9879952

ABSTRACT

Survival, weight loss, translocation and histological alterations in the terminal ileum, liver and spleen were studied in mice simultaneously immunosuppressed with cyclophosphamide and treated or not with Saccharomyces boulardii until the death of all animals. The animals were divided into five groups: C1 (not immunosuppressed, not treated); C2 (immunosuppressed, not treated); B1 (immunosuppressed, treated with S. boulardii 10.0 mg); B2 (immunosuppressed, treated with S. boulardii 1.0 mg) and B3 (immunosuppressed, treated with S. boulardii 0.1 mg). Survival was higher in group B3 than in the other immunosuppressed groups. Weight loss was observed for all groups except C1. By day 7, some animals from each group were killed by ether inhalation for the determination of bacterial translocation and histopathological examination. Bacterial translocation to the liver was lower in groups C1 and B3 than in the other groups. The highest translocation to the liver and spleen was observed in group B1. Low S. boulardii translocation was observed in some animals, principally to the mesenteric lymph nodes. Histopathological examination showed a decrease in epithelial cell turnover with villus length reduction and loss of brush borders in group C2. Relative protection against these alterations was obtained when the animals were treated with the yeast, independently of the dose. Higher expression of the lymphoid component was also noted in the ileal lamina propria, liver and spleen of mice treated with the yeast, together with activation of the reticulo-endothelial system, when compared with group C2 where lymphocyte depletion was observed. This study suggests a relative protection of immunosuppressed animals by treatment with S. boulardii, but this phenomenon was inversely proportional to the yeast dose.


Subject(s)
Bacterial Translocation , Immunocompromised Host , Immunologic Deficiency Syndromes/therapy , Saccharomyces/physiology , Animals , Body Weight , Cyclophosphamide , Disease Models, Animal , Ileum/pathology , Immunologic Deficiency Syndromes/epidemiology , Immunologic Deficiency Syndromes/mortality , Immunosuppression Therapy , Immunosuppressive Agents , Intestinal Mucosa/pathology , Life Tables , Liver/microbiology , Lymph Nodes/microbiology , Male , Mesentery , Mice , Morbidity , Spleen/microbiology
11.
Nutr Cancer ; 28(2): 212-7, 1997.
Article in English | MEDLINE | ID: mdl-9290130

ABSTRACT

Swiss mice fed commercial or elemental diets and an oral short-chain fatty acid (SCFA) solution or saline were treated with the cytostatic drug Ara-C (cytarabine, 3.6 mg/mouse/day) for two or four days. Histopathological examination revealed less damage (atrophy, inflammation, or necrosis) to the small intestine and colon caused by Ara-C when SCFA was administered. Accordingly, protein and nucleotide concentrations in the intestinal mucosa were higher in the group receiving SCFA than in the group receiving a placebo of the same pH and osmolarity. Improvement by SCFA treatment was correlated with an increase in the height of the intestinal villi, with no alterations of the crypts. Furthermore, the number of intraepithelial lymphocytes was similar to normal values in animals receiving SCFA and Ara-C. When large doses of SCFA were administered, xanthomized enterocytes appeared, suggesting an accumulation of fatty acids in these cells. We conclude that oral administration of SCFA at close to physiological proportions reduces the inflammation and necrosis caused by Ara-C administration, thus representing a potential factor for the improvement of patients with mucositis caused by cancer treatment.


Subject(s)
Antimetabolites, Antineoplastic/toxicity , Cytarabine/toxicity , Fatty Acids, Volatile/therapeutic use , Intestinal Diseases/drug therapy , Intestinal Mucosa/pathology , Administration, Oral , Animals , Antimetabolites, Antineoplastic/administration & dosage , Cohort Studies , Cytarabine/administration & dosage , Diet , Fatty Acids, Volatile/administration & dosage , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/pathology , Intestinal Diseases/chemically induced , Intestinal Diseases/pathology , Intestinal Mucosa/drug effects , Intestine, Small/chemistry , Intestine, Small/drug effects , Mice , Nucleotides/analysis
12.
Arq. biol. tecnol ; 39(4): 961-74, dez.1996. tab, graf
Article in English | LILACS | ID: lil-238887

ABSTRACT

The hypercholesterolemia is one of the most relevant risk factors in atherosclerosis, the latter being responsible for a high mortality in most Western countries. A high intake of foods from plant origin is one of the recommendations for the control of hypercholesterolemia, probably because of their fiber content. This study was designed to evaluate the effects of the ingestion a pumpkin-based diet on cholesterol levels. Fifty mices were divided in three groups: I, animals fed on normocholesterolemic control diet: II, animals fed on a hypercholesterolemic diet; III, animals fed on a hypercholesterolemic diet containing dehydrated pumpkin during 8 weeks. The results showed that dehydrated pumpkin, when administered in high concentration in the diet, reduced the levels of plasmatic and hepatic cholesterol but may caue relevant lesions in liver. Further studies are necessary to evaluate the right proportion of pumpkin to reduce the cholesterolemia without undesirable effects. This study reinforces the need for the continuous support of an experienced histopathologist to detect eventual damage that are not evident on macroscopic examination in all nutritional studies involving tests with diets


Subject(s)
Animals , Rats , Cholesterol , Dietary Fiber , Hypercholesterolemia , Hyperlipidemias , Tannins
13.
Toxicon ; 34(10): 1119-25, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8931252

ABSTRACT

In the present study we report the distribution of Tityus serrulatus scorpion venom in serum and various tissues of CFI mice and the efficacy of antivenom in reducing venom concentration. The animals were injected s.c. with 10 micrograms of scorpion venom, divided into groups of four animals and killed at different times from 15 min to 24 hr. Blood samples and samples of different tissues (heart, lung, liver, kidney, spleen, brain and injection site) were collected. Maximum venom levels occurred at 15 min in the kidney and liver and at 30 min in serum, lung, heart and spleen. After 2 hr the venom decreased rapidly in serum and in all other organs until venom levels were no longer detectable after 8 hr. No venom was detected in the central nervous system. In another experiment, 10 microliters of scorpion antivenom was injected i.v. together with the venom, and a rapid reduction of venom concentration was observed in the blood and tissues. In the third experiment, anti-scorpion venom was injected i.v. 1 hr after venom administration, and partial reduction of venom concentration was detected in tissues (lung and kidney). These studies contribute to the elaboration of more objective treatment that may result in a more economic, efficient and controlled use of scorpion antivenom in stings involving humans.


Subject(s)
Antivenins/pharmacology , Scorpion Venoms/pharmacokinetics , Scorpions , Animals , Enzyme-Linked Immunosorbent Assay , Mice , Tissue Distribution/drug effects
14.
J Appl Bacteriol ; 81(3): 251-6, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8810053

ABSTRACT

Saccharomyces boulardii was shown to be capable of inhibiting multiplication of enteropathogenic bacteria in vitro and is currently used for its anti-diarrhoea properties. We studied the capacity of this yeast to antagonize Salmonella typhimurium and Shigella flexneri in the intestinal tract of conventional or gnotobiotic NMRI mice. Conventional animals were given daily 10 mg doses of S. boulardii, whereas germ-free animals were given a single 10 mg dose. Both groups were challenged orally 5 d later with the pathogenic bacteria (10(8) or 10(2) viable cells, respectively). Control groups were treated with saline instead of S. boulardii. Mortality and/or histopathological data showed a protective effect against the pathogenic bacteria in yeast-treated mice. Saccharomyces boulardii colonized the digestive tract of gnotobiotic mice and the number of viable cells ranged around 10(10) g-1 of faeces. In experimental and control gnotobiotic animals, Salm. typhimurium and Sh. flexneri became rapidly established at a level of about 10(10) viable cells g-1 of faeces and remained at high levels until the animals died or were sacrificed. The protection against Salm. typhimurium and Sh. flexneri obtained in conventional and/or gnotobiotic mice previously associated with S. boulardii is not due to the reduction of the bacterial populations in the intestines.


Subject(s)
Antibiosis , Dysentery, Bacillary/prevention & control , Saccharomyces/growth & development , Salmonella Infections, Animal/prevention & control , Salmonella typhimurium/growth & development , Shigella flexneri/growth & development , Administration, Oral , Animals , Colony Count, Microbial , Dysentery, Bacillary/mortality , Feces/microbiology , Germ-Free Life , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Liver/pathology , Mice , Salmonella Infections, Animal/mortality
15.
J Pediatr (Rio J) ; 72(1): 32-4, 1996.
Article in Portuguese | MEDLINE | ID: mdl-14688972

ABSTRACT

The present study describes 21 cases (17 females and 01 male) of 12 year old patients, or younger, with diagnosis of SLE, that were submitted to renal biopsy. The histologic study demonstrated 10 cases of membranoproliferative glomerulonephritis (Class IV-WHO); 4 cases of focal proliferative glomerulonephritis (Class III-WHO; 2 cases of mesangial proliferative glomerulonephritis (Class II-WHO) and 2 cases of membranous glomerulonephritis (Class V-WHO). Three cases were excluded. In this study the incidence of lupus nephritis in children was small, similar to what has been described by other authors, and presenting unfavorable histologic patterns.

16.
Braz J Med Biol Res ; 28(3): 323-5, 1995 Mar.
Article in English | MEDLINE | ID: mdl-8520525

ABSTRACT

The effect of orogastric administration of Saccharomyces boulardii on the anatomopathological aspect of the jejunal villi was studied in male Fischer rats (weighing about 40 g) orogastrically infected with a culture of Vibrio cholerae. Experimental and control groups received lyophilized S. boulardii (25 mg suspended in 0.5 ml saline) or 0.5 ml saline, respectively, three times a day for 10 days by gastric intubation. On day 5 of treatment, 0.5 ml of a culture of V. cholerae containing 10(8) viable cells was inoculated by gastric intubation into both groups. Histopathological examination of the jejunal mucosa showed extensive lesions of the superficial epithelium of the villi from the control group whereas few lesions of this superficial epithelium were observed in the experimental group. These data show that the inhibition of the action of the cholera toxin on enterocytes by S. boulardii suggested by recent results in vitro can be demonstrated in vivo.


Subject(s)
Cholera Toxin , Intestinal Mucosa/pathology , Jejunum/pathology , Saccharomyces/physiology , Vibrio cholerae/pathogenicity , Animals , Male , Rats , Rats, Inbred Strains
18.
Braz. j. med. biol. res ; 28(3): 323-5, Mar. 1995. ilus
Article in English | LILACS | ID: lil-154697

ABSTRACT

The effect of orogastric administration of Saccharomyces boulardii on the anatomopathological aspect of the jejunal villi was studied in male Fischer rats (weighing about 40 g) orogastrically infected with a culture of Vibrio cholerae. Experimental and control groups received lyophilized S. boulardii (25 mg suspended in 0.5 ml saline) or 0.5 ml saline, respectively, three times a day for 10 days by gastric intubation. On day 5 of treatment, 0.5 ml of a culture of V. cholerae containing 10(8) viable cells was inoculated by gastric intubation into both groups. Histopathological examination of the jejunal mucosa showed extensive lesions of the superficial epithelium of the villi from the control group whereas few lesions of this superficial epithelium were observed in the experimental group. These data show that the inhibition of the action of the cholera toxin on enterocytes by S. boulardii suggested by recent results in vitro can be demonstrated in vivo


Subject(s)
Animals , Rats , Cholera Toxin/antagonists & inhibitors , Intestinal Mucosa/pathology , Jejunum/pathology , Saccharomyces/physiology , Vibrio cholerae/pathogenicity , Rats, Inbred Strains
20.
Comp Biochem Physiol Comp Physiol ; 106(4): 813-21, 1993 Dec.
Article in English | MEDLINE | ID: mdl-7906641

ABSTRACT

1. Conventional (CV) and gnotobiotic (GN) female CFW mice were infected with the Y strain of Trypanosoma cruzi. 2. After infection, both CV and GN groups received injections of iron-dextran or desferrioxamine. Non-injected mice served as controls. 3. The parasitemia was more intense in iron-dextran-treated mice. 4. The iron levels in serum, liver, and spleen were: (a) not decreased by desferrioxamine and (b) increased by iron-dextran treatments. 5. An increase in leukocyte numbers was observed in all GN and CV groups after infection. 6. There was no difference in total iron binding capacity (TIBC) and iron saturation transferrin (IST) between GN and CV mice before infection. 7. In CV groups, after infection, TIBC was decreased whereas the levels of IST were increased; in GN the opposite occurred. 8. Trypanosome-specific IgG and IgM antibody levels were raised in the GN group but not in the CV group.


Subject(s)
Chagas Disease/physiopathology , Germ-Free Life/physiology , Iron/pharmacology , Nutritional Status/physiology , Animals , Chagas Disease/parasitology , Chagas Disease/pathology , Deferoxamine/therapeutic use , Erythrocyte Count , Female , Immunoglobulin G/metabolism , Immunoglobulin M/metabolism , Iron/blood , Iron Deficiencies , Iron-Dextran Complex/therapeutic use , Leukocyte Count , Mice , Mice, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...